Preventive impact of probiotic supplements on heart injury and inflammatory indices in a rat model of myocardial infarction: histopathological and gene expression evaluation
APMIS · 2025
DOI: 10.1111/apm.13479 ↗Kurz gefasst
Fachartikel in der Zeitschrift APMIS, 2025. Verfasst von Samad Farashi Bonab und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Probiotics, Myocardial Infarction, Disease Models, Animal, Myocardium. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Although there is a bulk of evidence on the favorable effect of probiotics on the cardiac system, their role in the management of myocardial infarction is not clear. Three viable probiotic bacterial strains, namely Lactobacillus reuteri , Bifidobacterium longum , and Bifidobacterium lactis , were gavaged to the rats daily for 28 days prior to the induction of myocardial injury. Myocardial injury was induced by the use of isoproterenol (ISO) in the probiotics, control and sham groups. The heart tissues were catheterized to evaluate the histopathological parameters and measure the expression of genes related to inflammation. Treatment with ISO caused subendocardial necrosis and rupture of cardiac myofibrils. Pretreatment with probiotics reduced the size of myocardial infarction caused by ISO. Also, in the probiotic group, a relative decrease in the amount of tissue fibrosis and rupture of cardiomyocytes fibers was seen. Pretreatment with probiotics partially ameliorated myocardial necrosis, edema and leukocyte infiltration. Also, a remarkable decrease was detected in the expression of tissue proinflammatory genes in the pretreated group with probiotics. Thus, viable probiotic supplementation may ameliorate or prevent cardiac injury. Additional preclinical and clinical studies are required to clarify the impact of probiotics in the prevention and management of cardiovascular disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Faculty of Converging Sciences and Technologies, Science and Research Branch, Photonic, Biology and Cognitive Science Research Center, Islamic Azad University, Tehran, Iran.
- Department of Biology, Faculty of Science, Arak Branch, Islamic Azad University, Arak, Iran.
- Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Dietary Supplements and Probiotic Research Center, Alborz University of Medical Sciences, Karaj, Iran.
ORCID-Profile: Soudeh Ghafouri-Fard
Zitieren
APA
Bonab, S. F., Tahmasebi, S., Ghafouri-Fard, S., & Eslami, S. (2025). Preventive impact of probiotic supplements on heart injury and inflammatory indices in a rat model of myocardial infarction: histopathological and gene expression evaluation. APMIS. https://doi.org/10.1111/apm.13479
Vancouver
Bonab SF, Tahmasebi S, Ghafouri-Fard S, Eslami S. Preventive impact of probiotic supplements on heart injury and inflammatory indices in a rat model of myocardial infarction: histopathological and gene expression evaluation. APMIS. 2025. doi:10.1111/apm.13479
BibTeX
@article{Bonab2025,
author = {Bonab, Samad Farashi and Tahmasebi, Saeed and Ghafouri-Fard, Soudeh and Eslami, Solat},
title = {Preventive impact of probiotic supplements on heart injury and inflammatory indices in a rat model of myocardial infarction: histopathological and gene expression evaluation},
journal = {APMIS},
year = {2025},
doi = {10.1111/apm.13479}
}
EUVIMED